Lisata Therapeutics(LSTA) - 2024 Q3 - Quarterly Results

Exhibit 99.1 Lisata Therapeutics Reports Third Quarter 2024 Financial Results and Provides Business Update Robust and expanding development portfolio with multiple key data readouts projected over the next 18 months Conference call scheduled for today at 4:30 p.m. Eastern Time BASKING RIDGE, N.J. (November 12, 2024) – Lisata Therapeutics, Inc. (Nasdaq: LSTA) ("Lisata" or the "Company"), a clinicalstage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and othe ...